IBM has recently announced a groundbreaking collaboration with the global research company Boehringer Ingelheim to harness the power of artificial intelligence (AI) foundation models in the quest for new antibody treatments. Antibody treatments are a potent weapon against many serious diseases, offering fewer side effects than traditional treatments. The partnership aims to develop a foundational ... Read more